Pauling David — SEC Form 4 filings

SEC reporting owner CIK 2063633. 5 Form 4 filings on record with FilingPulse; latest filed 2026-03-06.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2025-04-08 to 2026-03-06. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
SUTRO BIOPHARMA, INC. (STRO)Chief Admin. Ofcr. & GC51 leg · 12,504 sh · $9,99316

Form 4 filings — Pauling David

FiledFormIssuerReported transactionsSource
2026-03-064SUTRO BIOPHARMA, INC. (STRO)Option exercise (M): 675 @ $0 · Tax withholding (F): 277 @ $21.31 · Option exercise (M): 675 (derivative) @ $0EDGAR
2026-03-034SUTRO BIOPHARMA, INC. (STRO)Option exercise (M): 500 @ $0 · Option exercise (M): 842 @ $0 · Tax withholding (F): 551 @ $20.47 · Option exercise (M): 2,356 @ $0 · Tax withholding (F): 970 @ $20.55 · Option exercise (M): 500 (derivative) @ $0 · +4 moreEDGAR
2025-12-294SUTRO BIOPHARMA, INC. (STRO)Grant/award (A): 7,200 (derivative) @ $0EDGAR
2025-10-164SUTRO BIOPHARMA, INC. (STRO)Purchase (P): 12,504 @ $0.80EDGAR
2025-04-084SUTRO BIOPHARMA, INC. (STRO)Grant/award (A): 101,500 (derivative) @ $0 · Grant/award (A): 94,250 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2063633 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →